Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 90% ± 10% | |
GABAergic neuron | 10 studies | 50% ± 22% | |
glutamatergic neuron | 10 studies | 60% ± 23% | |
retina horizontal cell | 7 studies | 80% ± 11% | |
astrocyte | 6 studies | 43% ± 17% | |
interneuron | 5 studies | 45% ± 27% | |
endothelial cell | 4 studies | 33% ± 11% | |
granule cell | 4 studies | 33% ± 27% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 91% ± 1% | |
neuron | 3 studies | 26% ± 8% | |
GABAergic interneuron | 3 studies | 33% ± 12% | |
oligodendrocyte | 3 studies | 34% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 38% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10103.80 | 2639 / 2642 | 98% | 188.32 | 693 / 705 |
adrenal gland | 3% | 56.60 | 9 / 258 | 66% | 10.85 | 151 / 230 |
lung | 13% | 210.26 | 77 / 578 | 3% | 0.06 | 31 / 1155 |
pancreas | 0% | 0 | 0 / 328 | 11% | 0.43 | 19 / 178 |
breast | 0% | 0 | 0 / 459 | 5% | 0.33 | 61 / 1118 |
eye | 0% | 0 | 0 / 0 | 5% | 0.20 | 4 / 80 |
liver | 0% | 0 | 0 / 226 | 4% | 0.15 | 17 / 406 |
intestine | 2% | 25.24 | 22 / 966 | 2% | 0.04 | 9 / 527 |
skin | 0% | 0.55 | 1 / 1809 | 4% | 0.19 | 18 / 472 |
uterus | 0% | 0 | 0 / 170 | 3% | 0.07 | 15 / 459 |
stomach | 0% | 0 | 0 / 359 | 3% | 0.07 | 9 / 286 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.40 | 24 / 901 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.07 | 1 / 45 |
esophagus | 0% | 0 | 0 / 1445 | 2% | 0.05 | 4 / 183 |
thymus | 0% | 1.38 | 1 / 653 | 1% | 0.15 | 5 / 605 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.03 | 4 / 430 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.02 | 4 / 502 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.06 | 4 / 504 |
heart | 0% | 1.08 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0008306 | Biological process | associative learning |
GO_0050805 | Biological process | negative regulation of synaptic transmission |
GO_0007155 | Biological process | cell adhesion |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0051971 | Biological process | positive regulation of transmission of nerve impulse |
GO_0048692 | Biological process | negative regulation of axon extension involved in regeneration |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0050808 | Biological process | synapse organization |
GO_0007158 | Biological process | neuron cell-cell adhesion |
GO_0035641 | Biological process | locomotory exploration behavior |
GO_0022029 | Biological process | telencephalon cell migration |
GO_0048677 | Biological process | axon extension involved in regeneration |
GO_0097402 | Biological process | neuroblast migration |
GO_0007411 | Biological process | axon guidance |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0022408 | Biological process | negative regulation of cell-cell adhesion |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0045121 | Cellular component | membrane raft |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0072534 | Cellular component | perineuronal net |
GO_0090733 | Cellular component | tenascin complex |
Gene name | TNR |
Protein name | TNR protein Tenascin-R (TN-R) (Janusin) (Restrictin) Tenascin R |
Synonyms | |
Description | FUNCTION: Neural extracellular matrix (ECM) protein involved in interactions with different cells and matrix components. These interactions can influence cellular behavior by either evoking a stable adhesion and differentiation, or repulsion and inhibition of neurite growth. Binding to cell surface gangliosides inhibits RGD-dependent integrin-mediated cell adhesion and results in an inhibition of PTK2/FAK1 (FAK) phosphorylation and cell detachment. Binding to membrane surface sulfatides results in a oligodendrocyte adhesion and differentiation. Interaction with CNTN1 induces a repulsion of neurons and an inhibition of neurite outgrowth. Interacts with SCN2B may play a crucial role in clustering and regulation of activity of sodium channels at nodes of Ranvier. TNR-linked chondroitin sulfate glycosaminoglycans are involved in the interaction with FN1 and mediate inhibition of cell adhesion and neurite outgrowth. The highly regulated addition of sulfated carbohydrate structure may modulate the adhesive properties of TNR over the course of development and during synapse maintenance (By similarity). . |
Accessions | ENST00000367674.7 [Q92752-1] H0Y668 ENST00000422274.2 A1L306 Q92752 |